Research Area
HIV
Research focused on prevention, treatment, long-term health and improving outcomes for people living with HIV.
Research & Clinical Trials
Advancing infectious disease care through research.
VIDC conducts innovative clinical research focused on improving the prevention, diagnosis and treatment of HIV, hepatitis C and other infectious diseases.
Evidence-Based Research
Participant-Centred
Clinical Innovation
VIDC Research
Connecting scientific discovery with better care
Research Areas
Focused research. Broader impact.
VIDC’s research brings together clinical knowledge, scientific investigation and community experience to explore better approaches to prevention, diagnosis, treatment and long-term care.
Research Area
Research Area
Hepatitis C
Studies exploring hepatitis C testing, treatment, prevention and barriers that may affect access to care.
Research Area
Addiction Treatment (OAT)
Research focused on Opioid Agonist Treatment (OAT), treatment access, continuity of care and approaches that support people with opioid use disorder.
VIDC Research
Discovery connected to real-world care
Research at VIDC
Research that connects discovery with better care.
At VIDC, research is closely connected to the realities of clinical care. By bringing scientific investigation, medical expertise and community understanding together, we work to improve care for people affected by HIV, hepatitis C and other infectious diseases.
This integrated approach helps translate research into meaningful outcomes, supporting better prevention, treatment and long-term health in the communities we serve.
Scientific research
Clinical experience
Community-informed care
Better health outcomes
Current Studies
Explore research opportunities at VIDC.
Review current studies, observational research and community-based research initiatives at VIDC.
Eligibility and recruitment details may change. Review each study carefully and contact VIDC for current participation information.
Research Area
Study Type
Minimal Risk Specimen Collection Protocol
SL 1506-001 Minimal Risk Specimen Collection
A minimal risk specimen collection protocol supporting the development and evaluation of diagnostic assays across multiple therapeutic areas.
Diagnostics & Biorepository
Prospective Observational Cohort
The Canadian Co-infection Cohort
A national prospective observational cohort examining the health impacts of direct-acting antivirals for people living with HIV and hepatitis C coinfection.
HIV & Hepatitis C
Phase 3 Clinical Trial
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With Coronavirus Disease 2019 (COVID-19) Who Are Not Hospitalized But Are at Risk For Severe Disease
A Phase 3 study evaluating the efficacy and safety of ibuzatrelvir in non-hospitalized adults and adolescents with symptomatic COVID-19 who are at high risk of severe disease.
COVID-19
Phase 2 Clinical Trial
Aligos Therapeutics Chronic Hepatitis B Phase 2 Study
A Phase 2 clinical research study evaluating a potential new treatment for adults living with chronic hepatitis B who have not previously received treatment.
Hepatitis B
Community Testing & Care Initiative
Community Pop-Up Clinics for Hepatitis C & HIV Testing and Care in Vancouver’s Inner City
Low-barrier community pop-up clinics providing point-of-care hepatitis C and HIV testing, rapid treatment initiation, and wraparound care.
Community Testing & Outreach
HIV & Hepatitis C
Accessible Addiction Clinic Program
Opioid Agonist Treatment Program
A specialized treatment and support program for individuals managing opioid use disorder, combining evidence-based medications, clinical monitoring, and integrated health services.
Community Care & Support
No current studies match those filters.
Study Eligibility
Could one of these studies be right for you?
Complete the short eligibility form so the VIDC research team can review which current study opportunities may be relevant to you.
Research Participation
What to expect when participating in a study.
Every clinical study is different, but VIDC’s research team helps participants understand each step, ask questions and make an informed decision before taking part. Participation is always voluntary.
Voluntary Participation
Informed Consent
Privacy & Confidentiality
01
Explore a Study
Review current research opportunities and learn about the purpose of each study, its research area and what the study is designed to investigate.
02
Connect With the Research Team
Ask questions, discuss the study and learn whether the opportunity may be relevant to you before moving forward.
03
Review Eligibility & Consent
The research team explains screening, study requirements, procedures, possible risks and benefits, privacy protections and what participation may involve.
04
Participate With Ongoing Support
Eligible participants receive clear instructions, opportunities to ask questions and continued support throughout their involvement in the study.
Research FAQ
Questions about research participation.
Learn more about clinical studies at VIDC, including eligibility, consent, privacy and what participation may involve. Details can vary between studies, so the research team will provide the approved information for each opportunity.
Study details can vary. Eligibility, screening, visits, compensation and study procedures are specific to each research opportunity.
Who can participate in a clinical study?
Eligibility requirements vary depending on the study. The research team will review the study criteria and explain whether an opportunity may be appropriate.
Do I need to be a current VIDC patient?
Not necessarily. Participation requirements differ between studies. Contact the research team to confirm whether current VIDC care is required.
Is research participation voluntary?
Yes. Deciding whether to take part is your choice. Participants receive information about the study and can ask questions before making a decision.
What happens during the screening process?
Screening may include a conversation with the research team, a review of relevant health information and study-specific assessments. The exact process will be explained before screening begins.
Are there costs for participating?
Costs, reimbursements or compensation may vary by study. The research team will explain any financial information associated with a specific opportunity.
Can I stop participating after joining?
Participation is voluntary. The approved consent information for each study will explain how withdrawal works and whether any follow-up steps may be required.
How is my information protected?
Participant information is handled according to the privacy and confidentiality requirements applicable to the individual study. The research team will explain how information is collected, used and protected.
How do I learn about available studies?
Browse the Current Studies section or contact the VIDC research team for information about recruiting and upcoming opportunities.